Copyright Reports & Markets. All rights reserved.

Global Rabies Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Rabies Vaccine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Vero Cell Rabies Vaccine
      • 1.2.2 BHK
      • 1.2.3 Chick Embryo Cell Rabies Vaccine
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pre-exposure Prophylaxis
      • 1.3.2 Post-exposure Prophylaxis
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GSK (Novartis)
      • 2.1.1 Business Overview
      • 2.1.2 Rabies Vaccine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi-Pasteur
      • 2.2.1 Business Overview
      • 2.2.2 Rabies Vaccine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Chengda
      • 2.3.1 Business Overview
      • 2.3.2 Rabies Vaccine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Chengda Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Yisheng
      • 2.4.1 Business Overview
      • 2.4.2 Rabies Vaccine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Prcmise
      • 2.5.1 Business Overview
      • 2.5.2 Rabies Vaccine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 VACN
      • 2.6.1 Business Overview
      • 2.6.2 Rabies Vaccine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 VACN Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Changsheng
      • 2.7.1 Business Overview
      • 2.7.2 Rabies Vaccine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 BCHT
      • 2.8.1 Business Overview
      • 2.8.2 Rabies Vaccine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 BCHT Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Hissen
      • 2.9.1 Business Overview
      • 2.9.2 Rabies Vaccine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Hissen Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Rabies Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Rabies Vaccine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Rabies Vaccine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Rabies Vaccine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Rabies Vaccine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Rabies Vaccine Market Analysis by Regions

    • 4.1 Global Rabies Vaccine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Rabies Vaccine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Rabies Vaccine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 4.3 Europe Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 4.5 South America Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Rabies Vaccine Sales and Growth Rate (2014-2019)

    5 North America Rabies Vaccine by Country

    • 5.1 North America Rabies Vaccine Sales, Revenue and Market Share by Country
      • 5.1.1 North America Rabies Vaccine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Rabies Vaccine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 5.3 Canada Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Rabies Vaccine Sales and Growth Rate (2014-2019)

    6 Europe Rabies Vaccine by Country

    • 6.1 Europe Rabies Vaccine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Rabies Vaccine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Rabies Vaccine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 6.3 UK Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 6.4 France Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 6.5 Russia Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 6.6 Italy Rabies Vaccine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Rabies Vaccine by Country

    • 7.1 Asia-Pacific Rabies Vaccine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Rabies Vaccine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Rabies Vaccine Revenue and Market Share by Country (2014-2019)
    • 7.2 China Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 7.3 Japan Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 7.4 Korea Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 7.5 India Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Rabies Vaccine Sales and Growth Rate (2014-2019)

    8 South America Rabies Vaccine by Country

    • 8.1 South America Rabies Vaccine Sales, Revenue and Market Share by Country
      • 8.1.1 South America Rabies Vaccine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Rabies Vaccine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Rabies Vaccine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Rabies Vaccine by Countries

    • 9.1 Middle East and Africa Rabies Vaccine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Rabies Vaccine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Rabies Vaccine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Rabies Vaccine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Rabies Vaccine Sales and Growth Rate (2014-2019)

    10 Global Rabies Vaccine Market Segment by Type

    • 10.1 Global Rabies Vaccine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Rabies Vaccine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Rabies Vaccine Revenue and Market Share by Type (2014-2019)
    • 10.2 Vero Cell Rabies Vaccine Sales Growth and Price
      • 10.2.1 Global Vero Cell Rabies Vaccine Sales Growth (2014-2019)
      • 10.2.2 Global Vero Cell Rabies Vaccine Price (2014-2019)
    • 10.3 BHK Sales Growth and Price
      • 10.3.1 Global BHK Sales Growth (2014-2019)
      • 10.3.2 Global BHK Price (2014-2019)
    • 10.4 Chick Embryo Cell Rabies Vaccine Sales Growth and Price
      • 10.4.1 Global Chick Embryo Cell Rabies Vaccine Sales Growth (2014-2019)
      • 10.4.2 Global Chick Embryo Cell Rabies Vaccine Price (2014-2019)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2014-2019)
      • 10.5.2 Global Other Price (2014-2019)

    11 Global Rabies Vaccine Market Segment by Application

    • 11.1 Global Rabies Vaccine Sales Market Share by Application (2014-2019)
    • 11.2 Pre-exposure Prophylaxis Sales Growth (2014-2019)
    • 11.3 Post-exposure Prophylaxis Sales Growth (2014-2019)

    12 Rabies Vaccine Market Forecast (2019-2024)

    • 12.1 Global Rabies Vaccine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Rabies Vaccine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Rabies Vaccine Market Forecast (2019-2024)
      • 12.2.2 Europe Rabies Vaccine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Rabies Vaccine Market Forecast (2019-2024)
      • 12.2.4 South America Rabies Vaccine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Rabies Vaccine Market Forecast (2019-2024)
    • 12.3 Rabies Vaccine Market Forecast by Type (2019-2024)
      • 12.3.1 Global Rabies Vaccine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Rabies Vaccine Market Share Forecast by Type (2019-2024)
    • 12.4 Rabies Vaccine Market Forecast by Application (2019-2024)
      • 12.4.1 Global Rabies Vaccine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Rabies Vaccine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

      Scope of the Report:
      Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
      Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
      The most wildly used rabies vaccine is Vero cell rabies vaccine (VRV), which takes about 80.85% in 2016.
      Nowadays, global rabies vaccine production is mainly concentrated in China, Europe and North America. In 2016, China rabies vaccine production takes about 74.34% and Europe production takes about 7.46%.
      The worldwide market for Rabies Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Rabies Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      GSK (Novartis)
      Sanofi-Pasteur
      Chengda
      Yisheng
      Prcmise
      VACN
      Changsheng
      BCHT
      Hissen

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Vero Cell Rabies Vaccine
      BHK
      Chick Embryo Cell Rabies Vaccine
      Other

      Market Segment by Applications, can be divided into
      Pre-exposure Prophylaxis
      Post-exposure Prophylaxis

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Rabies Vaccine product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Rabies Vaccine, with price, sales, revenue and global market share of Rabies Vaccine in 2017 and 2018.
      Chapter 3, the Rabies Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Rabies Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Rabies Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now